Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Myelofibrosis and TNF[original query] |
---|
Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients. Blood cells, molecules & diseases 2016 Mar 57 54-7. Macedo Luciana Conci, de Cesare Quintero Fernanda, Pagliari-E-Silva Sara, Pagnano Katia Borgia Barbosa, Rodrigues Camila, de Alencar Josiane Bazzo, Sell Ana Maria, Visentainer Jeane Eliete Lagui |
MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes. Journal of translational medicine 2021 6 19 (1): 233. Guo Chao, Gao Ya-Yue, Ju Qian-Qian, Wang Min, Zhang Chun-Xia, Gong Ming, Li Zhen-Li |
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study. The Lancet. Haematology 2022 5 9 (6): e434-e444. Pemmaraju Naveen, Garcia Jacqueline S, Potluri Jalaja, Harb Jason G, Sun Yan, Jung Paul, Qin Qin Q, Tantravahi Srinivas K, Verstovsek Srdan, Harrison Clai |
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study. Cancers 2023 3 15 (5): . Messerich Nora-Medea, Uda Narasimha Rao, Volken Thomas, Cogliatti Sergio, Lehmann Thomas, Holbro Andreas, Benz Rudolf, Graf Lukas, Gupta Vikas, Jochum Wolfram, Demmer Izadora, Rao Tata Nageswara, Silzle Tobi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: